PGXL Laboratories is a pioneering force in the field of pharmacogenetics testing, serving as both a commercial entity and a research lab. By effectively bridging the gap between these two realms, the company is spearheading the advancement of personalized medicine, actively contributing to the realms of discovery, assay development, and clinical testing. Through PGXL's services, physicians and researchers benefit from unparalleled scientific expertise. The widespread application of pharmacogenetics to personalized medicine is projected to significantly improve patient outcomes while concurrently curbing healthcare expenses. Established in 2005, the company operates within the biotechnology and healthcare sectors and is committed to empowering physicians in the adoption of personalized medicine as a standard practice in healthcare.
There is no investment information
No recent news or press coverage available for PGXL Laboratories.